Tanoto Foundation Backs Landmark Research to Unlock the Code of Asian Prevalent Diseases
Understanding Asian Cancers and Diabetes Through an Asian Lens
NCCS and SGH secure research funding from Tanoto Foundation for projects tackling Asian-prevalent cancers and young-onset diabetes to drive breakthroughs in regional health
Breast Cancer in Asian Women, marked by earlier onset and biological differences compared to Western populations
T/NK-Cell Lymphomas, an aggressive blood cancer dominant in East Asians with limited treatment options
Bile Duct Cancer (Cholangiocarcinoma), increasingly linked to environmental exposures specific to Asia
Rare Asian Cancers, collectively neglected but accounting for up to 25% of all cases in the region
SINGAPORE - Media OutReach Newswire - 27 June 2025 -Tanoto Foundation today announced the funding of two transformative, Singapore-based medical research projects focused on diseases that disproportionately affect Asian populations: prevalent and aggressive cancers, and young-onset Type 2 diabetes. The multi-year initiatives aim to generate data-driven insights that can accelerate diagnosis, improve patient outcomes, and guide public health policy.Despite global strides in medicine, Asia continues to face rising rates of cancer and diabetes – diseases that are biologically and clinically distinct in Asian populations but remain under-researched due to a lack of region-specific data. The two research projects, from National Cancer Centre Singapore and Singapore General Hospital, will focus on filling these gaps through deep genomic studies and innovative risk-prediction models.Imelda Tanoto, Member of the Board of Trustees, Tanoto Foundation said: "Singapore is well-positioned to lead in medical science. It has strong research institutions and a population that reflects the diversity of Asia. By supporting researchers here who are focused on health issues that affect Asians, we hope to help drive discoveries that make a real difference to people's lives — both in Singapore and across the region."Led by Dr Jason Chan, Medical Oncologist, National Cancer Centre Singapore, the research will investigate four types of cancers with high prevalence and poor outcomes in Asia:These cancers are devastating but remain poorly understood because most research has focused on Western populations," said Dr Chan. "By decoding their molecular and genomic landscapes in Asian patients, we want to uncover new diagnostic and therapeutic opportunities to benefit patients."A key feature of the project is its open-access commitment: anonymised data will be freely available to the broader research community to accelerate further discovery and collaboration.The second research project, led by Dr Daphne Gardner, Endocrinologist, Singapore General Hospital, will address the rising incidence of Type 2 diabetes in young adults, particularly prevalent in Singapore, where 1 in 5 young adults have prediabetes or diabetes, despite being of normal weight.Unlike traditional assessments that rely heavily on BMI and family history, this project will develop a next-generation risk prediction tool by incorporating non-traditional indicators such as body fat distribution, continuous glucose monitoring, and health-seeking behaviour."Many young Asians with diabetes don't fit the usual risk profile. They're lean, active, and often overlooked by current screening models," said Dr Gardner. "We want to change that by identifying new risk signals and developing tools that are tailored to Singapore's population and beyond."Findings from the study aim to inform national diabetes screening guidelines and lead to earlier interventions that can curb long-term complications.In addition to previously supported research projects, these two initiatives reflect a growing recognition of Singapore's role in advancing precision medicine for Asian populations, driven by strong clinical infrastructure, genomic capabilities, and public-private partnerships.Imelda Tanoto added: "We believe precision health can change how we treat and prevent diseases. We're supporting researchers who are not only breaking new ground, but also making sure their work reaches people and communities across Asia. This is something deeply personal to us — it's about improving lives in a way that's inclusive, meaningful, and lasting."This announcement marks a key milestone in Tanoto Foundation's continuing effort to improve the quality of healthcare and health standards, leading to longer and better healthspans.Hashtag: #TanotoFoundation
The issuer is solely responsible for the content of this announcement.
About Tanoto Foundation
At Tanoto Foundation, we unlock human potential, help communities thrive, and create lasting impact. Founded in 1981 by Sukanto Tanoto and Tinah Bingei Tanoto, we are an independent family foundation that believes in providing every person with the opportunity to realize his or her full potential. To do so, we catalyse systems change in education and healthcare. Our approach is impact-first, collaborative, and evidence-based. We invest for the long term and strive to develop leaders who can drive sustained, positive outcomes.
More information is available at www.tanotofoundation.org/en/.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
9 hours ago
- The Sun
Tanoto Foundation Backs Landmark Research to Unlock the Code of Asian Prevalent Diseases
SINGAPORE - Media OutReach Newswire - 27 June 2025 - Tanoto Foundation today announced the funding of two transformative, Singapore-based medical research projects focused on diseases that disproportionately affect Asian populations: prevalent and aggressive cancers, and young-onset Type 2 diabetes. The multi-year initiatives aim to generate data-driven insights that can accelerate diagnosis, improve patient outcomes, and guide public health policy. Despite global strides in medicine, Asia continues to face rising rates of cancer and diabetes – diseases that are biologically and clinically distinct in Asian populations but remain under-researched due to a lack of region-specific data. The two research projects, from National Cancer Centre Singapore and Singapore General Hospital, will focus on filling these gaps through deep genomic studies and innovative risk-prediction models. Imelda Tanoto, Member of the Board of Trustees, Tanoto Foundation said: 'Singapore is well-positioned to lead in medical science. It has strong research institutions and a population that reflects the diversity of Asia. By supporting researchers here who are focused on health issues that affect Asians, we hope to help drive discoveries that make a real difference to people's lives — both in Singapore and across the region.' Tackling Asian-Prevalent Cancers Led by Dr Jason Chan, Medical Oncologist, National Cancer Centre Singapore, the research will investigate four types of cancers with high prevalence and poor outcomes in Asia: • Breast Cancer in Asian Women, marked by earlier onset and biological differences compared to Western populations • T/NK-Cell Lymphomas, an aggressive blood cancer dominant in East Asians with limited treatment options • Bile Duct Cancer (Cholangiocarcinoma), increasingly linked to environmental exposures specific to Asia • Rare Asian Cancers, collectively neglected but accounting for up to 25% of all cases in the region These cancers are devastating but remain poorly understood because most research has focused on Western populations,' said Dr Chan. 'By decoding their molecular and genomic landscapes in Asian patients, we want to uncover new diagnostic and therapeutic opportunities to benefit patients.' A key feature of the project is its open-access commitment: anonymised data will be freely available to the broader research community to accelerate further discovery and collaboration. Unmasking Diabetes Risk in Young Singaporeans The second research project, led by Dr Daphne Gardner, Endocrinologist, Singapore General Hospital, will address the rising incidence of Type 2 diabetes in young adults, particularly prevalent in Singapore, where 1 in 5 young adults have prediabetes or diabetes, despite being of normal weight. Unlike traditional assessments that rely heavily on BMI and family history, this project will develop a next-generation risk prediction tool by incorporating non-traditional indicators such as body fat distribution, continuous glucose monitoring, and health-seeking behaviour. 'Many young Asians with diabetes don't fit the usual risk profile. They're lean, may not have hypertension, and are therefore often overlooked by current screening models,' said Dr Gardner. 'We want to change that by identifying new risk signals and developing tools that are tailored to Singapore's population and the region.' Findings from the study aim to inform national diabetes screening guidelines and lead to earlier interventions that can curb long-term complications. Singapore as a Hub for Medical Research Advancement In addition to previously supported research projects, these two initiatives reflect a growing recognition of Singapore's role in advancing precision medicine for Asian populations, driven by strong clinical infrastructure, genomic capabilities, and public-private partnerships. Imelda Tanoto added: 'We believe precision health can change how we treat and prevent diseases. We're supporting researchers who are not only breaking new ground, but also making sure their work reaches people and communities across Asia. This is something deeply personal to us — it's about improving lives in a way that's inclusive, meaningful, and lasting.' This announcement marks a key milestone in Tanoto Foundation's continuing effort to improve the quality of healthcare and health standards, leading to longer and better healthspans. Hashtag: #TanotoFoundation The issuer is solely responsible for the content of this announcement.
Malay Mail
10 hours ago
- Malay Mail
Scorching reality: Europe's medics share tips on spotting and stopping deadly heatstroke
MADRID, June 27 — As dangerously high temperatures sweep across parts of the United States and southern Europe this week, emergency workers are racing to mitigate the public health risk of heatstroke. Spanish rescuers took AFP through the warning signs and best responses to the potentially fatal condition, as a heatwave grips Spain, Portugal, France and the Balkans. Scientists warn that periods of extreme heat will become longer, more frequent and more intense as human-induced climate change accelerates. Symptoms In a large room at Madrid's Isabel Zendal hospital, emergency medical staff adjusted their headphones and fixed their gaze on their computer screens. They receive 3,500 calls every day, some caused by falls, fainting and other dangers linked to overheating. But identifying heatstroke straight away is 'difficult', said Gemma Rodriguez, a team leader at the SUMMA 112 emergency service. The symptoms can 'point to another condition, for example, an unconscious person, a person who has fallen over... or has trauma, and the primary cause could have been heatstroke', she told AFP. To diagnose the condition, doctors typically examine whether the patient has a body temperature of over 40 degrees Celsius; whether their skin is hot and dry; or whether they are sweating heavily, nauseous or vomiting, she added. In extreme cases, heatstroke can cause incoherent speech and loss of consciousness, and can even prove fatal if left untreated. Rodriguez said vulnerable groups like children, the elderly and people with chronic illnesses should pay particular attention to the warning signs. She recalled the case of an elderly couple with Alzheimer's disease who spent several hours in the sun in the countryside in early June. The man tumbled into a ditch and the woman fainted, but they are now out of danger thanks to the intervention of SUMMA 112, she told AFP. Treatment When someone has heatstroke, the priority is to bring down their body temperature, for example by moving them into the shade or an air-conditioned room — anything to shield them from the sun, Rodriguez explained. 'Another method is to use compresses, cool them with serums, or (apply) water and ice' to the armpits, forehead, neck, genital area and stomach, she said. 'In the most extreme and serious cases', Rodriguez added, patients may need to be given therapeutic serums intravenously. Prevention To avoid heatstroke, people should avoid sun exposure during the hottest hours of the day, generally from midday to 4pm, Rodriguez said. The advice is particularly relevant to sports enthusiasts and people who work outdoors, like street sweepers and labourers, she added as she unfolded a survival blanket designed to keep patients cool. It is also important to stay hydrated, wear light clothing and caps, and stay in the shade or air-conditioned spaces, Rodriguez told AFP. For active types unable to resist a workout, she had a simple message: 'avoid those (hot) hours or do it in an air-conditioned room'. — AFP
Malay Mail
13 hours ago
- Malay Mail
Tanoto Foundation Backs Landmark Research to Unlock the Code of Asian Prevalent Diseases
Understanding Asian Cancers and Diabetes Through an Asian Lens NCCS and SGH secure research funding from Tanoto Foundation for projects tackling Asian-prevalent cancers and young-onset diabetes to drive breakthroughs in regional health Breast Cancer in Asian Women, marked by earlier onset and biological differences compared to Western populations T/NK-Cell Lymphomas, an aggressive blood cancer dominant in East Asians with limited treatment options Bile Duct Cancer (Cholangiocarcinoma), increasingly linked to environmental exposures specific to Asia Rare Asian Cancers, collectively neglected but accounting for up to 25% of all cases in the region SINGAPORE - Media OutReach Newswire - 27 June 2025 -Tanoto Foundation today announced the funding of two transformative, Singapore-based medical research projects focused on diseases that disproportionately affect Asian populations: prevalent and aggressive cancers, and young-onset Type 2 diabetes. The multi-year initiatives aim to generate data-driven insights that can accelerate diagnosis, improve patient outcomes, and guide public health global strides in medicine, Asia continues to face rising rates of cancer and diabetes – diseases that are biologically and clinically distinct in Asian populations but remain under-researched due to a lack of region-specific data. The two research projects, from National Cancer Centre Singapore and Singapore General Hospital, will focus on filling these gaps through deep genomic studies and innovative risk-prediction Tanoto, Member of the Board of Trustees, Tanoto Foundation said: "Singapore is well-positioned to lead in medical science. It has strong research institutions and a population that reflects the diversity of Asia. By supporting researchers here who are focused on health issues that affect Asians, we hope to help drive discoveries that make a real difference to people's lives — both in Singapore and across the region."Led by Dr Jason Chan, Medical Oncologist, National Cancer Centre Singapore, the research will investigate four types of cancers with high prevalence and poor outcomes in Asia:These cancers are devastating but remain poorly understood because most research has focused on Western populations," said Dr Chan. "By decoding their molecular and genomic landscapes in Asian patients, we want to uncover new diagnostic and therapeutic opportunities to benefit patients."A key feature of the project is its open-access commitment: anonymised data will be freely available to the broader research community to accelerate further discovery and second research project, led by Dr Daphne Gardner, Endocrinologist, Singapore General Hospital, will address the rising incidence of Type 2 diabetes in young adults, particularly prevalent in Singapore, where 1 in 5 young adults have prediabetes or diabetes, despite being of normal traditional assessments that rely heavily on BMI and family history, this project will develop a next-generation risk prediction tool by incorporating non-traditional indicators such as body fat distribution, continuous glucose monitoring, and health-seeking behaviour."Many young Asians with diabetes don't fit the usual risk profile. They're lean, active, and often overlooked by current screening models," said Dr Gardner. "We want to change that by identifying new risk signals and developing tools that are tailored to Singapore's population and beyond."Findings from the study aim to inform national diabetes screening guidelines and lead to earlier interventions that can curb long-term addition to previously supported research projects, these two initiatives reflect a growing recognition of Singapore's role in advancing precision medicine for Asian populations, driven by strong clinical infrastructure, genomic capabilities, and public-private Tanoto added: "We believe precision health can change how we treat and prevent diseases. We're supporting researchers who are not only breaking new ground, but also making sure their work reaches people and communities across Asia. This is something deeply personal to us — it's about improving lives in a way that's inclusive, meaningful, and lasting."This announcement marks a key milestone in Tanoto Foundation's continuing effort to improve the quality of healthcare and health standards, leading to longer and better #TanotoFoundation The issuer is solely responsible for the content of this announcement. About Tanoto Foundation At Tanoto Foundation, we unlock human potential, help communities thrive, and create lasting impact. Founded in 1981 by Sukanto Tanoto and Tinah Bingei Tanoto, we are an independent family foundation that believes in providing every person with the opportunity to realize his or her full potential. To do so, we catalyse systems change in education and healthcare. Our approach is impact-first, collaborative, and evidence-based. We invest for the long term and strive to develop leaders who can drive sustained, positive outcomes. More information is available at
